English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This editorial refers to ‘EuroEco: aprovider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring’, by H. Heidbuchel et al. , on page doi:10.1093/eurheartj/ehu339 Over several decades, electrically active devices have been implanted and later checked on a regular basis in an outpatient clinic, mainly for three purposes: (i) to ensure the technical integrity of the lead and device, (ii) to check device-detected biological events, which may or may not have gone unnoticed by the patient but which can be of major relevance to the patient's outcome, such as silent atrial fibrillation in combination with a high risk score for embolism and (iii) to gain an overall impression, from the patient's visits, of his or her cardiac status, symptom score, any medical event, and compliance to drug regimen. In comparison with ‘traditional’ pacemaker outpatients, remotely monitored patients require a clinical setup that allows the remote supervision of electrocardiogram (ECG) data, including urgent contact or intervention.From my point of view, remote monitoring of electrically active devices has not only been gaining significant momentum but actually has the potential to improve the safety of device-therapy, quality of life, and substantial outcome parameters such as the …

Remote monitoring of implantable cardioverter-defibrillators: financial impact for providers and benefits to patients